These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 19818677
1. Perspectives of targeted mass spectrometry for protein biomarker verification. Hüttenhain R, Malmström J, Picotti P, Aebersold R. Curr Opin Chem Biol; 2009 Dec; 13(5-6):518-25. PubMed ID: 19818677 [Abstract] [Full Text] [Related]
2. Qualification and Verification of Protein Biomarker Candidates. Zhao Y, Brasier AR. Adv Exp Med Biol; 2016 Dec; 919():493-514. PubMed ID: 27975232 [Abstract] [Full Text] [Related]
3. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Shi T, Su D, Liu T, Tang K, Camp DG, Qian WJ, Smith RD. Proteomics; 2012 Apr; 12(8):1074-92. PubMed ID: 22577010 [Abstract] [Full Text] [Related]
5. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis. Lin L, Zheng J, Yu Q, Chen W, Xing J, Chen C, Tian R. J Proteomics; 2018 Mar 01; 174():9-16. PubMed ID: 29278786 [Abstract] [Full Text] [Related]
6. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer. Hüttenhain R, Choi M, Martin de la Fuente L, Oehl K, Chang CY, Zimmermann AK, Malander S, Olsson H, Surinova S, Clough T, Heinzelmann-Schwarz V, Wild PJ, Dinulescu DM, Niméus E, Vitek O, Aebersold R. Mol Cell Proteomics; 2019 Sep 01; 18(9):1836-1850. PubMed ID: 31289117 [Abstract] [Full Text] [Related]
8. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry. Keshishian H, Burgess MW, Specht H, Wallace L, Clauser KR, Gillette MA, Carr SA. Nat Protoc; 2017 Aug 01; 12(8):1683-1701. PubMed ID: 28749931 [Abstract] [Full Text] [Related]
9. Discovery of Candidate Biomarkers. Wiktorowicz JE, Soman KV. Adv Exp Med Biol; 2016 Aug 01; 919():443-462. PubMed ID: 27975230 [Abstract] [Full Text] [Related]
10. Biomarker validation by targeted mass spectrometry. McIntosh M, Fitzgibbon M. Nat Biotechnol; 2009 Jul 01; 27(7):622-3. PubMed ID: 19587666 [No Abstract] [Full Text] [Related]
11. Targeted and Untargeted Proteomics Approaches in Biomarker Development. Sobsey CA, Ibrahim S, Richard VR, Gaspar V, Mitsa G, Lacasse V, Zahedi RP, Batist G, Borchers CH. Proteomics; 2020 May 01; 20(9):e1900029. PubMed ID: 31729135 [Abstract] [Full Text] [Related]
12. Targeted proteomics: a bridge between discovery and validation. Harlan R, Zhang H. Expert Rev Proteomics; 2014 Dec 01; 11(6):657-61. PubMed ID: 25348939 [Abstract] [Full Text] [Related]
13. Toward an integrated pipeline for protein biomarker development. Drabovich AP, Martínez-Morillo E, Diamandis EP. Biochim Biophys Acta; 2015 Jun 01; 1854(6):677-86. PubMed ID: 25218201 [Abstract] [Full Text] [Related]
14. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry. Ahn YH, Ji ES, Oh NR, Kim YS, Ko JH, Yoo JS. J Proteomics; 2014 Jun 25; 106():221-9. PubMed ID: 24780727 [Abstract] [Full Text] [Related]